Prevalence and Predictive Factors for Celiac Disease in Children With Type 1 Diabetes. Whom and When to Screen? A Nationwide Longitudinal Cohort Study of Swedish Children.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
16 Feb 2024
Historique:
received: 08 09 2023
accepted: 28 01 2024
medline: 16 2 2024
pubmed: 16 2 2024
entrez: 16 2 2024
Statut: aheadofprint

Résumé

To examine the prevalence and predictive factors for celiac disease (CD) after a diagnosis of type 1 diabetes (T1D) in children and adolescents, to improve the current screening guidelines. The association between sex, age at T1D diagnosis, HLA, and diabetes autoantibodies, and a diagnosis of CD was examined in 5,295 children with T1D from the Better Diabetes Diagnosis study in Sweden. The prevalence of biopsy-proven CD was 9.8%, of which 58.2% already had a CD diagnosis before or at T1D onset. Almost all, 95.9%, were diagnosed with CD within 5 years after the T1D diagnosis. Younger age at the T1D diagnosis and being homozygote for DQ2 increased the risk of CD after T1D, but neither sex nor diabetes-related autoantibodies were associated with the risk. Age at and time after diabetes diagnosis should be considered in screening guidelines for CD in children with T1D.

Identifiants

pubmed: 38363973
pii: 154238
doi: 10.2337/dc23-1671
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by the American Diabetes Association.

Auteurs

Marie Lindgren (M)

Department of Clinical Science, Lund University, Lund, Sweden.
Department of Paediatrics, Vrinnevi Hospital, Norrköping, Sweden.

Fredrik Norström (F)

Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.

Martina Persson (M)

Department of Medicine, Clinical Epidemiology, Karolinska University Hospital, Stockholm, Sweden.

Helena Elding Larsson (HE)

Department of Clinical Science Malmö, Lund University, Lund, Sweden.
Department of Paediatrics, Skåne University Hospital, Malmö/Lund, Sweden.

Gun Forsander (G)

Department of Paediatrics, Institute for Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.

Karin Åkesson (K)

Division of Paediatrics, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Department of Paediatrics, County Hospital Ryhov, Jönköping, Sweden.

Ulf Samuelsson (U)

Division of Paediatrics, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Crown Princess Victoria Children's Hospital, Linköping University Hospital, Linköping, Sweden.

Johnny Ludvigsson (J)

Division of Paediatrics, Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.
Crown Princess Victoria Children's Hospital, Linköping University Hospital, Linköping, Sweden.

Annelie Carlsson (A)

Department of Clinical Science, Lund University, Lund, Sweden.
Department of Paediatrics, Skåne University Hospital, Malmö/Lund, Sweden.

Classifications MeSH